Details
Stereochemistry | ACHIRAL |
Molecular Formula | C31H32N4O2 |
Molecular Weight | 492.6114 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=C1C=CC=C5
InChI
InChIKey=FLKWNFFCSSJANB-UHFFFAOYSA-N
InChI=1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4913411 |
Primary | Burgodin Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report). | 1970 Apr |
|
Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. | 2003 Nov |
|
The use of driving impairing medicines: a European survey. | 2009 Nov |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6519169
5 mg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
||
|
WHO-VATC |
QN02AC05
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
||
|
WHO-ATC |
N02AC05
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
||
|
DEA NO. |
9800
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2104149
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
DB01459
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
m2470
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
239-335-4
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
BEZITRAMIDE
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
3KXW0Y310I
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
C72109
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
100000085875
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
DTXSID90165197
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
15301-48-1
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
1942
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
363
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
SUB05811MIG
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY | |||
|
61791
Created by
admin on Sat Dec 16 16:07:12 GMT 2023 , Edited by admin on Sat Dec 16 16:07:12 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PRODRUG)
SALT/SOLVATE (PARENT)